City

Duarte (1)

Seattle (1)

Overall Status

Recruiting (1)

Terminated (1)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

City of Hope Medical Center (1)

Fred Hutchinson Cancer Center (1)

Collaborator

National Cancer Institute (NCI) (1)

Study Documents

Intervention Type

biological (2)

drug (1)

other (1)

procedure (1)

radiation (1)

Funder Type

Other (2)

Study Type

Interventional (2)

hematopoietic cell transplant recipient

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,

Terminated

Acute Biphenotypic Leukemia
+29 more

Cyclophosphamide
+7 more

Seattle, Washington

Fred Hutch/University of Washington Cancer Consortium

Jan 4, 2023

Cytomegaloviral Infection, Hematopoietic Cell Transplant Recipient Trial in Duarte (Laboratory Biomarker Analysis, Multi-peptide

Recruiting

Cytomegaloviral Infection
Hematopoietic Cell Transplant Recipient

Laboratory Biomarker Analysis
Multi-peptide CMV-Modified Vaccinia Ankara Vaccine

Duarte, California

City of Hope Medical Center

Jun 14, 2022